Literature DB >> 29052400

[Protective effect of ginsenoside Rb₁ on doxorubicin-induced myocardial autophagy].

Long-Fei Li1, Zeng-Chun Ma1, Yu-Guang Wang1, Xiang-Lin Tang1, Hong-Ling Tan1, Cheng-Rong Xiao1, Yue Gao1.   

Abstract

Ginsenoside Rb₁ (Rb₁), which is one of the main ingredients derived from Panax ginseng, has been found to have extensive pharmacological activities including antioxidant, anti-inflammatory, anticancer properties. In this study, the effect of Rb₁ on doxorubicin-induced myocardial autophagy was studied with H9c2 as the study object. CCK-8 method, transmission electron microscope observation, fluorescence staining observation and Western blot were used to detect changes in H9c2 cell proliferation and autophagy after treatment. According to the results, doxorubicin could cause cell viability decrease, significant increase in the LC3-Ⅱ/LC3-I ratio and down-regulation of the expression of p62. Pretreatment with ginsenoside Rb₁ inhibited cell viability decrease and increase in doxorubicin-induced autophagic structure and LC3-Ⅱ/LC3-I ratio, and down-regulation of the expression of p62. In conclusion, doxorubicin could induce H9c2 cell death and induce autophagy, and ginsenoside Rb₁ showed a protective effect on DOX-induced cardiotoxicity, which may be correlated with suppression of DOX-induced autophagy. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  H9c2 cell ; autophagy ; doxorubicin ; ginsenoside Rb₁;

Mesh:

Substances:

Year:  2017        PMID: 29052400     DOI: 10.19540/j.cnki.cjcmm.20170222.009

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression.

Authors:  Yuan Lu; Wen Liu; Ting Lv; Yanli Wang; Ting Liu; Yi Chen; Yang Jin; Jin Huang; Lin Zheng; Yong Huang; Yan He; Yongjun Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Cordyceps sinensis-mediated biotransformation of notoginsenoside R1 into 25-OH-20(S/R)-R2 with elevated cardioprotective effect against DOX-induced cell injury.

Authors:  Jishuang Liu; Yu Xin; Zhidong Qiu; Qi Zhang; Tianzhu He; Ye Qiu; Weinan Wang
Journal:  RSC Adv       Date:  2022-04-28       Impact factor: 4.036

Review 3.  Progress on the efficacy and mechanism of action of panax ginseng monomer saponins treat toxicity.

Authors:  Xinyi Wang; Rongcan Wang; Yongfei Qiao; Yali Li
Journal:  Front Pharmacol       Date:  2022-09-19       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.